CD83 and ovarian cancer: Next, we examined the involvement of p-ERK1/2-FOXO1-p21 and STAT3-DKK1 signaling pathways in the regulation of proliferation and stemness of ovarian cancer cells by the newly-identified CD83-TAK1-TAB1 complex.